Latest News
Recent market gains are being fueled by speculative retail buying while institutional investors remain on the sidelines.
Via Talk Markets · May 13, 2025
UnitedHealth stock tanks as CEO announces resignation and company pulls guidance.
Via Talk Markets · May 13, 2025
We're starting to see some pretty big numbers get thrown around by the banks.
Via Talk Markets · May 13, 2025
There is a growing consensus amongst trade specialists that ultimate resting point for U.S. tariffs will be a global tariff of 10%, and slightly higher for China.
Via Talk Markets · May 13, 2025
We should all be relieved that there’s been a 90 day pause in the tariffs on Chinese imports, but since they’re on tap in 90 days, and at unknown levels, don’t be surprised that uncertainty remains high.
Via Talk Markets · May 13, 2025
Via Benzinga · May 13, 2025
Technology, semiconductors, and crypto are still outperforming right now, which points to a healthy risk appetite for stocks.
Via Talk Markets · May 13, 2025
Via Benzinga · May 13, 2025
Via Benzinga · May 13, 2025
Via Benzinga · May 13, 2025
Via Benzinga · May 13, 2025
American Eagle Outfitters Inc (NYSE:AEO) shares are tumbling in Tuesday's after-hours session after the company reported preliminary results for the first quarter and withdrew its full-year guidance.
Via Benzinga · May 13, 2025
Via The Motley Fool · May 13, 2025
When growth stocks pull back and tech valuations start to look shaky, Amazon quietly reminds long-term investors why it’s a powerhouse—not just a hype play.
Via Talk Markets · May 13, 2025
U.S. inflation rose 2.3% annually in April, with shelter costs up and key goods like used cars and apparel posting monthly price declines.
Via Benzinga · May 13, 2025
Via Benzinga · May 13, 2025
Here's a look at Nu Holdings' first-quarter earnings report.
Via Benzinga · May 13, 2025
Easing U.S.-China trade tensions and cooler inflation data fueled another round of risk-on buying today.
Via Talk Markets · May 13, 2025
Roche's APHINITY study shows promising results for HER2-positive breast cancer treatment with Perjeta regime
Via Benzinga · May 13, 2025
Via Benzinga · May 13, 2025
Via Benzinga · May 13, 2025
ClearPoint Neuro announces Q1 earnings, beating revenue estimates but missing earnings estimates. Company affirms full-year sales guidance.
Via Benzinga · May 13, 2025